SI-BONE, Inc.
SIBN · XNASCIK 1459839fmd_1DMMG14FSPE7EJAM63FYN48F3MManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 37 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 48 | 55 | 67 | 73 | 90 | 106 | 139 | 167 | 201 |
| Cost of revenue | 5 | 5 | 7 | 9 | 10 | 16 | 29 | 35 | 41 |
| Gross profit | 43 | 51 | 61 | 64 | 80 | 91 | 109 | 132 | 160 |
| Research and development | 6 | 5 | 7 | 9 | 12 | 14 | 15 | 17 | 17 |
| Selling, general and administrative | 55 | 57 | 89 | 94 | 119 | 137 | 141 | 151 | 165 |
| Total operating expenses | 60 | 63 | 97 | 103 | 131 | 150 | 156 | 167 | 182 |
| Operating income | (17) | (12) | (36) | (39) | (52) | (60) | (47) | (35) | (22) |
| Interest expense | 6 | 5 | 5 | 6 | 5 | 3 | 3 | 3 | 3 |
| Interest and investment income | 0 | 1 | 3 | 1 | 0 | 1 | 7 | 8 | 6 |
| Other non-operating income (expense) | 0 | (1) | (0) | (0) | 0 | (0) | 0 | (0) | (0) |
| Income before taxes | (23) | (17) | (38) | (44) | (57) | (61) | (43) | (31) | (19) |
| Income tax expense | 0 | 0 | – | – | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (23) | (17) | – | – | (57) | (61) | (43) | (31) | (19) |
| Net income | (23) | (17) | (38) | (44) | (57) | (61) | (43) | (31) | (19) |